Jason mccarthy maxim group
Web7 feb. 2024 · Maxim Group analyst Jason McCarthy maintained a Buy rating on Actinium Pharmaceuticals (ATNM – Research Report) yesterday and set a price target of … WebAcum 7 ore · Maxim Group analyst Jason McCarthy downgrades Biocept (NASDAQ:BIOC) from Buy to Hold. ... Maxim Group Downgrades Biocept to Hold. by [email protected]. April 14, 2024 8:12 AM 18 seconds read.
Jason mccarthy maxim group
Did you know?
WebMerchant. Capital. Our team is well positioned to leverage our global resources and match emerging growth companies with high-quality financial and strategic investors. Our skilled specialists have significant experience in raising private capital for both late-stage and early-stage private and public companies across a range of industries ... Web17 dec. 2024 · Maxim Group initiated coverage of Cyclo Therapeutics (NASDAQ:CYTH) with a “buy” rating and $12 price target. The stock closed at $3.85 on Dec. 16. Cyclo is developing a Phase 3-ready hydroxypropyl beta cyclodextrin-based drug candidate, Trappsol Cyclo, to treat Niemann-Pick disease type C (NPC), a rare progressive genetic …
Web26 mai 2024 · The panel will include an interactive discussion moderated by Jason McCarthy, Ph.D., Maxim Group Senior Managing Director, Biotechnology. WebMaxim Group, LLC. Naz Rahman Jason McCarthy. Oppenheimer & Co. Francois Brisebois. Truist Securities. Srikripa Devarakonda Robyn Karnauskas. William Blair & Co. Tim Lugo. financial information. A comprehensive library of key 9 Meters reports. check out helpful investor resources View resources.
Web17 feb. 2024 · Maxim Group raised its price target for Artelo Biosciences (NASDAQ:ARTL) to $5 from $3, citing rising valuations across the cannabinoid and cannabis space, and as Artelo begins to map out its path forward as a cancer therapeutics company. The stock was changing hands at $2.70 at midday on Feb. 17. Analyst Jason McCarthy, Ph.D., writes … Web30 mar. 2024 · Bionano Genomics (BNGO) 2nd Annual Maxim Group Conference March 30, 2024, 3:30 PM ET. Seeking Alpha - Go to Homepage. Trending. ... Michael Okunewitch — Maxim Group. Jason McCarthy.
Web2 feb. 2024 · In an industry wide series of research reports, Maxim Group analyst Jason McCarthy, Ph.D., lowered price targets on stocks in his coverage universe, saying …
Web3 mar. 2024 · According to TipRanks.com, Maxim Group analyst Jason McCarthy is currently ranked with 5 stars on a 0-5 stars ranking scale, with an average return of … express credit careersWeb13 mai 2024 · Maxim Group raised its price target for Annovis Bio (NYSE American: ANVS) to $45 from $12, citing upcoming Phase 2a data evaluating ANVS401 in Alzheimer’s. … express credit careers namibiaWeb19 ian. 2024 · Stephen Kilmer. January 19, 2024. Maxim Group launched coverage of INVO Biosciences (NASDAQ:INVO) with a “buy” rating and $7 price target. The stock closed at $3.69 on Jan. 18. INVO is a commercial-stage company with the world’s first and only intravaginal culture device, INVOcell, for patients seeking treatment for infertility. Analyst ... express credit card rewardsWeb16 mar. 2024 · Jason McCarthy Work Experience and Education. According to ZoomInfo records, Jason McCarthy’s professional experience began in 2004. Since then Jason … express credit card statusWeb23 mar. 2024 · In addition to the Company’s corporate presentation available on demand for registered attendees, N. Scott Fine, Chief Executive Officer and Lise Lund Kjems, MD, PhD, Chief Medical Officer of Cyclo Therapeutics will participate in a live fireside chat moderated by Jason McCarthy, PhD, Head of Biotechnology Research at Maxim Group, on ... express credit contactsWebJason McCarthy, Ph.D. is a Senior Managing Director covering the biotechnology industry at Maxim Group. Dr. McCarthy joined Maxim Group in July 2014. Prior to joining … express credit gaboroneWebAcum 1 zi · ContraFect (CFRX – Research Report) received a Buy rating and a $3.00 price target from Maxim Group analyst Jason McCarthy today. The company’s shares closed yesterday at $1.01. McCarthy ... bubbly cocktail book